Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00611624 · ClinicalTrials.gov registry record · NA
Mammosite Breast Brachytherapy Optimization in the Treatment of Breast Carcinoma
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT00611624 is a NA study that has completed, run by Yale University. The registered enrollment target is 28 participants.
The verdict
NCT00611624, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if Mammosite Catheter optimization using multiple dwell position delivery decreases skin toxicity over historically reported skin toxicity with the single dwell delivery method.
Interventions
- RADIATION Mammosite brachytherapy radiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2006-05 |
| Est. Completion | 2013-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00611624
The ClinicalTrials.gov registry entry for NCT00611624 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mammosite brachytherapy radiation is the first listed.
NCT00611624 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00611624 about?
NCT00611624 is a clinical study titled "Mammosite Breast Brachytherapy Optimization in the Treatment of Breast Carcinoma". The purpose of this study is to determine if Mammosite Catheter optimization using multiple dwell position delivery decreases skin toxicity over historically reported skin toxicity with the single dwell delivery method.
What is the current status of trial NCT00611624?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2006-05. Estimated completion is 2013-04.
What interventions are being tested in trial NCT00611624?
The interventions under investigation include: Mammosite brachytherapy radiation (RADIATION).
Who is sponsoring clinical trial NCT00611624?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.